These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32178572)

  • 21. Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells.
    Sim MW; Grogan PT; Subramanian C; Bradford CR; Carey TE; Forrest ML; Prince ME; Cohen MS
    Laryngoscope; 2016 May; 126(5):E184-90. PubMed ID: 26690734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix stiffness regulates the proliferation, stemness and chemoresistance of laryngeal squamous cancer cells.
    Hui L; Zhang J; Ding X; Guo X; Jiang X
    Int J Oncol; 2017 Apr; 50(4):1439-1447. PubMed ID: 28259905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.
    Lv Z; Yang Y; Yang C
    Int J Oncol; 2020 Jan; 56(1):69-84. PubMed ID: 31789398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma.
    Chen H; Xin Y; Zhou L; Huang JM; Tao L; Cheng L; Tian J
    Med Oncol; 2014 Nov; 31(11):246. PubMed ID: 25257554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDAC1 regulates the chemosensitivity of laryngeal carcinoma cells via modulation of interleukin-8 expression.
    Ding S; Tang Z; Jiang Y; Luo P; Qing B; Wei Y; Zhang S; Tang R
    Eur J Pharmacol; 2021 Apr; 896():173923. PubMed ID: 33539818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma.
    Li D; Feng J; Wu T; Wang Y; Sun Y; Ren J; Liu M
    Am J Pathol; 2013 Jan; 182(1):64-70. PubMed ID: 23141928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and significance of c-fos in resistant cell line TU177/VCR of larynx squamous cell carcinoma].
    Li GD; Hu XL; Xing JF; Shi RY; Li X; Li JF; Li TL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):281-285. PubMed ID: 29747253
    [No Abstract]   [Full Text] [Related]  

  • 29. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of TIP30 to chemoresistance in laryngeal carcinoma.
    Zhu M; Yin F; Yang L; Chen S; Chen R; Zhou X; Jing W; Fan X; Jia R; Wang H; Zheng H; Zhao J; Guo Y
    Cell Death Dis; 2014 Oct; 5(10):e1468. PubMed ID: 25321475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma.
    Fang W; Shen J
    Am J Otolaryngol; 2020; 41(3):102391. PubMed ID: 31932027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
    Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
    J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.
    Li S; Yue D; Chen X; Wang L; Li J; Ping Y; Gao Q; Wang D; Zhang T; Li F; Yang L; Huang L; Zhang Y
    Oncol Rep; 2015 Jan; 33(1):425-32. PubMed ID: 25351876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing LY6D Expression Inhibits Colon Cancer in Xenograft Mice and Regulates Colon Cancer Stem Cells' Proliferation, Stemness, Invasion, and Apoptosis via the MAPK Pathway.
    Duan J; Wang Y; Chen Y; Wang Y; Li Q; Liu J; Fu C; Cao C; Cong Z; Su M
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells.
    Wu Y; Zhang Y; Niu M; Shi Y; Liu H; Yang D; Li F; Lu Y; Bo Y; Zhang R; Li Z; Luo H; Cui J; Sang J; Xiang C; Gao W; Wen S
    Cell Physiol Biochem; 2018; 47(4):1696-1710. PubMed ID: 29949786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
    de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
    Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells.
    Karatas OF; Suer I; Yuceturk B; Yilmaz M; Hajiyev Y; Creighton CJ; Ittmann M; Ozen M
    Tumour Biol; 2016 Mar; 37(3):4183-92. PubMed ID: 26490990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.
    Zhao ZL; Zhang L; Huang CF; Ma SR; Bu LL; Liu JF; Yu GT; Liu B; Gutkind JS; Kulkarni AB; Zhang WF; Sun ZJ
    Sci Rep; 2016 Apr; 6():24704. PubMed ID: 27108536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.